SCHEMBL11111005

SCHEMBL11111005

CCC[C@@H]1CC2=CC(=O)C=C[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H]([C@@H]4C[C@@H]4[C@@]3(O)CCC(=O)O)[C@H]12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 2/20 0.45
CYP19A1 P11511 8/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HSD17B10 Q99714 3/20 0.39
NR3C1 P04150 3/20 0.39
HIF1A Q16665 3/20 0.39
CYP3A4 P08684 2/20 0.39
ABCB11 O95342 2/20 0.39
PGR P06401 2/20 0.39
TNF P01375 1/20 0.39
IL6 P05231 1/20 0.39
SERPINA6 P08185 1/20 0.39
NR3C2 P08235 1/20 0.39
AR P10275 1/20 0.39
GLUL P15104 1/20 0.39
ADAM17 P78536 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11129293 1.00 SHBG (0.45) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL11110732 0.95 CYP19A1 (0.44) SHBGCYP19A1LMNAMAPTHSD17B10
SCHEMBL11126765 0.95 CYP19A1 (0.44) SHBGCYP19A1LMNAMAPTHSD17B10
SCHEMBL11095036 0.84 SHBG (0.44) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL6706329 0.84 SHBG (0.44) SHBGCYP19A1LMNAMAPTHSD17B10
SCHEMBL11095042 0.84 SHBG (0.44) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL6705617 0.83 MEN1 (0.57) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL6705623 0.83 MEN1 (0.57) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL11110788 0.83 MEN1 (0.60) SHBGCYP19A1MEN1KMT2ATDP1
SCHEMBL11114508 0.83 MEN1 (0.60) SHBGCYP19A1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0106793-A1 7-Alpha-alkyl-17-alpha-pregn-4-ene-21,17-carbolactones and -21-carboxylic acid salts and procedures for manufacturing them and pharmaceutical preparations containing them SCHERING AKTIENGESELLSCHAFT (DE) 1984-04-25 EP claimed